Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00462891
Recruitment Status : Completed
First Posted : April 19, 2007
Last Update Posted : May 21, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Michael J. Barry, MD, Massachusetts General Hospital

Brief Summary:

RATIONALE: Screening may help doctors find breast cancer cells early and plan better treatment for breast cancer. The Mammography FastTrack program may be effective in increasing the number of patients who undergo mammography.

PURPOSE: This randomized clinical trial is studying the use of a Mammography FastTrack program to increase the number of women who undergo mammography.

Condition or disease Intervention/treatment Phase
Breast Cancer Other: IT System Not Applicable

Detailed Description:


  • Classify all patients within the Massachusetts General Primary Care-Practice Based Research Network (MGPC-PBRN) according to patient-primary care provider (PCP) linkage status.
  • Develop a breast cancer screening intervention program called Mammography FastTrack that facilitates the ordering of mammograms to be used either by PCPs (for PCP-linked patients) or by practice managers (for practice-linked patients).
  • Compare the impact of the Mammography FastTrack program on mammography screening rates in PCP-linked vs practice-linked patients overdue for breast cancer screening.

OUTLINE: This is a randomized, multicenter study.

Mammography-eligible women are linked to either a provider or a practice within the Massachusetts General Primary Care Practice-Based Research Network (MGPC-PBRN). Practices within the MGPC-PBRN are stratified according to baseline mammography screening rates (high vs low) and practice type (community health center vs hospital-based vs community-based) and are randomized to 1 of 2 arms.

  • Arm I: Physicians and practice managers receive e-mail alerts at months 1 and 3 informing them of the availability of mammography screening data for their panel of primary-care patients. A hyperlink refers the provider to a web-portal for the Mammography FastTrack program that lists all eligible patients who have not undergone mammography. The provider may then click a button to schedule, defer (providing reason for deferral), or provide the date of a recent mammogram.
  • Arm II: Practices continue standard care. At the end of 12 months, electronic report and billing data and a review of electronic health records are used to determine the completion of mammograms.

PROJECTED ACCRUAL: A total of 6,730 patients will be accrued for this study.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 6730 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Breast Cancer Screening and Follow-Up in a PBRN: The Mammography FastTrack Trial
Study Start Date : March 2007
Actual Primary Completion Date : March 2008

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: IT System
IT system to send reminder letters to patients overdue for breast cancer screening.
Other: IT System
No Intervention: Usual Care

Primary Outcome Measures :
  1. Proportion of overdue patients completing mammography screening in intervention and control groups [ Time Frame: 1 year ]
    Proportion of overdue patients completing mammography screening in intervention and control groups over the 1-year study.

Secondary Outcome Measures :
  1. Difference in percentage of patients overdue at baseline receiving mammogram during the study period in intervention and control practices at 6 months [ Time Frame: 1 year ]
  2. Comparison of time to mammography completion in intervention vs control groups [ Time Frame: 1 year ]
  3. Clinical and nonclinical outcomes recorded by Mammography FastTrack tool [ Time Frame: 1 year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes


  • Any outpatient at a participating Massachusetts General Primary Care Practice-Based Research Network (MGPC-PBRN) practice within the past 3 years

    • No patient who the Massachusetts General Hospital system lists as having a primary care provider who is not in one of the MGPC-PBRN networks (linking patients with a provider or practice)
    • No patient who is not linked to specific provider or practice (randomized portion of study)
  • Billing, scheduling, and clinical electronic data sources required
  • No mammogram within the past 2 years (randomized portion of study)
  • Hormone receptor status not specified


  • Age 42 to 69 years (randomized portion of study)
  • Female
  • Menopausal status not specified


  • No prior bilateral mastectomy (randomized portion of study)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00462891

Layout table for location information
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts General Hospital
National Cancer Institute (NCI)
Layout table for investigator information
Study Chair: Michael J. Barry, MD Massachusetts General Hospital
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Michael J. Barry, MD, Project Investigator, Massachusetts General Hospital Identifier: NCT00462891    
Other Study ID Numbers: 02-114
R21CA121908 ( U.S. NIH Grant/Contract )
First Posted: April 19, 2007    Key Record Dates
Last Update Posted: May 21, 2013
Last Verified: May 2013
Keywords provided by Michael J. Barry, MD, Massachusetts General Hospital:
breast cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases